InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.100 0.001 (1.01%)+
Announcement
Release
18 May 2026 8:57AM
Price at Release
$0.099
Full Release
download
Summary
Alcidion Group Limited has signed an Asset Sale Agreement to acquire the Kyra flow products from Telstra Health, strengthening its position as a leading provider of patient flow solutions in Australia, New Zealand, and the UK. This acquisition includes the Kyra Patient Flow Manager, Queue Manager, and Kyra IQ products, which are utilized across various Australian states and boast long-standing customer relationships. The transaction is structured with a $3.0 million upfront payment and a potential $1.0 million earn-out, funded from Alcidion's cash reserves. The acquisition is expected to be earnings accretive immediately, enhancing Alcidion's recurring revenue and margin profile. This strategic move aligns with Alcidion's growth strategy focused on sustainable, high-margin revenue and extending its market reach.
Key Points
  • Acquisition of Kyra flow products from Telstra Health by Alcidion Group Limited.
  • Strengthens Alcidion's position in patient flow solutions across ANZ and the UK.
  • Includes Kyra Patient Flow Manager, Queue Manager, and Kyra IQ products.
  • Kyra flow products have a significant presence in Queensland, Victoria, WA, and Tasmania.
  • Projected FY26 revenue of $3.7M and EBITDA of $1.1M.
  • $3.0M upfront payment with up to $1.0M earn-out based on revenue thresholds.
  • Transaction funded through Alcidion's existing cash reserves.
  • Acquisition expected to be immediately earnings accretive.
  • Strategically expands Alcidion's customer base and market footprint.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.